Mascaretti L, James V, Barbara J, Cárdenas J M, Blagoevska M, Haracić M, Rossi U
Blood Transfusion Centre, San Gerardo Hospital, Via Donizetti 106, 20052 Monza, Italy.
Transfus Med. 2004 Apr;14(2):105-12. doi: 10.1111/j.1365-3148.2004.0487.x.
In October 2001, representatives of 17 European countries (Albania, Bosnia-Herzegovina, Bulgaria, Croatia, Czech Republic, Federal Republic of Yugoslavia, Finland, France, Germany, Greece, Italy, Macedonia, Romania, Slovenia, Spain, Turkey and UK) met in Sarajevo at a course organized by the European School of Transfusion Medicine to discuss their countries' regulations concerning different aspects of the safety of blood transfusion. Results are summarized in tables to facilitate comparisons. Most countries (13/17) have specific transfusion laws and 9/17 have hospital-based systems as opposed to national organizations. Quality assurance is common among investigated countries (14/17). Voluntary associations are responsible for donor promotion in the majority of countries (13/17). Exclusively, voluntary non-remunerated donors are found in 5/17 countries, whereas in the remaining ones, incentives, family replacement and remuneration are mechanisms stimulating blood donation. Medical doctors using official selection criteria are checking donor suitability in virtually all countries, which also perform main microbiological testing. Regulations on good clinical use of blood and derivatives are present in most countries but applied only in some. Although the data presented need to be interpreted with some caution, this preliminary analysis shows that, although some significant differences still exist, the majority of countries studied are moving in the same direction to ensure safety of their blood supply.
2001年10月,17个欧洲国家(阿尔巴尼亚、波斯尼亚和黑塞哥维那、保加利亚、克罗地亚、捷克共和国、南斯拉夫联盟共和国、芬兰、法国、德国、希腊、意大利、马其顿、罗马尼亚、斯洛文尼亚、西班牙、土耳其和英国)的代表在萨拉热窝参加了由欧洲输血医学学院组织的一次课程,讨论各自国家关于输血安全不同方面的法规。结果汇总在表格中以便于比较。大多数国家(13/17)有专门的输血法律,17个国家中有9个国家采用基于医院的系统而非国家组织。在所调查的国家中,质量保证很普遍(14/17)。在大多数国家(13/17),自愿协会负责促进献血。只有5/17的国家只有自愿无偿献血者,而在其余国家,激励措施、家属替代献血和有偿献血是刺激献血的机制。几乎在所有国家,使用官方选择标准的医生都在检查献血者的适用性,这些国家也进行主要的微生物检测。大多数国家都有关于血液及血液制品良好临床使用的法规,但只有部分国家实施。尽管所呈现的数据需要谨慎解读,但这一初步分析表明,尽管仍存在一些显著差异,但大多数被研究国家都在朝着确保血液供应安全的同一方向发展。